Inside informationEnglish
AB Science reports completion of the step 3 of phase 1, evaluating the combination of AB8939 with venetoclax for the treatment of refractory or relapsed AML
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- AB Science
- Filed
- 29/06/2026, 07:59
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 110044_20260629